Latest:
Adjuvant Osimertinib in Early-Stage NSCLC: The ADAURA Trial
Advances in Testing and Targeted Therapy for NSCLC: Translating Evidence to Clinical Practice
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Heather A. Wakelee, MD, FASCO
Latest:
EGFR mNSCLC: Future Directions
Panelists discuss how despite significant advances in EGFR-targeted therapy, critical unmet needs persist in EGFR-positive non–small cell lung cancer (NSCLC), including the need for better strategies to combat resistance mechanisms, more effective treatments for brain metastases, improved options for uncommon EGFR mutations, and the development of biomarker-driven approaches to optimize sequencing of available therapies.
Heather A. Wakelee, MD, Stanford University Medical Center
Latest:
Experts on the Evaluation of CEACAM5-Targeted Therapy in NSCLC
Balazs Halmos, MD, Martin F. Dietrich, MD, PhD, Roy S. Herbst, MD, PhD, Suresh S. Ramalingam, MD, FACP, FASCO, Mark Socinski, MD, and Heather Wakelee, MD, FASCO, discuss the evaluation of CEACAM5 biomarker testing in non–small cell lung cancer.
Heather A. Zierhut, PhD, MS, CGC
Latest:
New Law Widens Access to Genetic Counseling but Licensure and Coverage Barriers Persist
Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.
Heather Yeo, MD, MHS
Latest:
There's an App for That: Keeping Patients and Physicians on Track
In a pilot study, funded by both the Society for Surgery of the Alimentary Tract and The Center for Advanced Digestive Care, researchers at Weill Cornell Medicine are testing a new mobile app that could help transform postoperative patient monitoring.